 The study found that the treatment success rate for drug-resistant tuberculosis, DRTB, in the Republic of Tajikistan has improved over the past few years. In 2014, the success rate was 46.3%, but it rose to 56% in 2017. Additionally, the percentage of patients who failed or separated from treatment dropped from 58% in 2015 to 37% in 2017. However, the percentage of patients who continued treatment also fell from 2.1% in 2015 to 1.4% in 2017. Despite these improvements, there is still room for improvement, as the overall success rate remains below 60%. This article was authored by PU Makhmadova, RU Makhmadova, K.A. Zakharova, and others.